SCHEMBL5728112

SCHEMBL5728112

Cc1c(OCCCN)c2cc(Cl)ccc2oc1=O.Nc1cccc(COc2cc(=O)oc3ccc(Cl)cc23)c1

nearest known ligand 0.47

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 2/20 0.47
▸ MAOA P21397 1/20 0.43
▸ MAOB P27338 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5727934 0.94 ACHE (0.45) ACHEMAOAMAOB
SCHEMBL3920848 0.84 — —
SCHEMBL3910264 0.81 MAOB (0.43) ACHEMAOAMAOB
Trifluoroacetic Acid SCHEMBL3918872 0.77 MRGPRX4 (0.44) —
SCHEMBL3911254 0.76 KCNA3 (0.49) MAOB
Trifluoroacetic Acid SCHEMBL3910245 0.73 MCL1 (0.42) ACHEMAOAMAOB
SCHEMBL3920121 0.73 KCNA3 (0.51) ACHEMAOB
SCHEMBL13840577 0.73 PKM (0.54) MAOAMAOB
SCHEMBL3914736 0.72 KCNA3 (0.50) ACHEMAOB
SCHEMBL3915228 0.70 KCNA3 (0.47) MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1667988-A1 COUMARINS AS INOS INHIBITORS Aventis Pharmaceuticals Inc. (US) 2006-06-14 — — EP disclosed
WO-2005026143-A1 COUMARINS AS INOS INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2005-03-24 — — WO disclosed
Send feedback